Showing results (21-30 of 157) with videos related to
Sort By:
Pageof 16
Journal of Affective Disorders|May 6, 2023
Brain structural and functional alterations in individuals with combined overweight/obesity and mood disorders: A systematic review of neuroimaging studiesXinhe Zhang, Lin Han, Chenxuan Lu, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 10, 2023
Potential biopsychosocial factors mediating/moderating the relationship between depressive symptoms and body size among children and adolescents: A systematic reviewBing Cao, Xiaoli Shao, Yefei Xiao, et al.Neurology and Therapy|April 2, 2025
Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative ReviewJuliana West, Maggie Li, Sabrina Wong, et al.Psychiatry Investigation|April 22, 2025
The Clinical Utility of Biomarkers in Diagnosing Major Depressive Disorder in Adults: A Systematic Review of Literature From 2013 to 2023Shi-Han Ang, Roger C Ho, Roger S McIntyre, et al.Journal of Affective Disorders|October 18, 2024
Impact of antidepressants on the composition of the gut microbiome: A systematic review and meta-analysis of in vivo studiesJann Gamboa, Gia Han Le, Sabrina Wong, et al.Journal of Affective Disorders|September 1, 2024
Effects of ketamine on metabolic parameters in depressive disorders: A systematic reviewSabrina Wong, Gia Han Le, Rodrigo Mansur, et al.Sleep Medicine|April 26, 2021
The associations between sleep situations and mental health among Chinese adolescents: A longitudinal studyWanxin Wang, Xueying Du, Yangfeng Guo, et al.Expert Opinion on Emerging Drugs|March 8, 2021
Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trialsAmna Majeed, Jiaqi Xiong, Kayla M Teopiz, et al.Journal of Psychiatric Research|October 18, 2025
Efficacy and safety profiles of FDA-approved dual orexin receptor antagonists in depression: A systematic review of pre-clinical and clinical studiesShreya Vasudeva, Sabrina Wong, Gia Han Le, et al.Journal of Affective Disorders|April 24, 2025
The Effects of Ketamine and Esketamine on Measures of Quality of Life in Major Depressive Disorder and Treatment-Resistant Depression: A Systematic ReviewMorgan C H Cheng, Christine E Dri, Hana Ballum, et al.Pageof 16